Discover 1,168 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
With a focus on a variety of conditions such as lymphoma, cancer, neurological diseases, and sleep apnea, Cincinnati is home to a wide array of clinical studies. The city's leading medical centers are actively recruiting participants, offering paid research opportunities for healthy volunteers or trials for specific health conditions, providing access to innovative treatments and therapies.
Filter
2
Filter results
Results: 1,168
Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)
for
Complex Cardiovascular Surgery With Cardiopulmonary Bypass
Location: Cincinnati OH, Chicago IL, London, Charlottesville VA,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT07094087
Phase 3, Recruiting
Study of Epcoritamab as a Consolidation Therapy in CLL/SLL
for
CLL/SLL, CLL, SLL, Chronic Lymphocytic Leukemia,
Location: Cincinnati OH
Sponsor: Zulfa Omer
Sex: All
Age: 18+
Code: NCT07108998
Phase 2, Recruiting
Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma,
Location: Cincinnati OH
Sponsor: Zulfa Omer
Sex: All
Age: 18+
Code: NCT07014917
Phase 2, Recruiting
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
for
Depressive Disorder, Major
Location: Cincinnati OH, Evanston IL, Atlanta GA, Chapel Hill NC,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 12 - 17
Code: NCT07227454
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
for
Thrombocytopenia, Neonatal Alloimmune
Location: Cincinnati OH, Detroit MI, Nashville TN, Park Ridge IL,
Sponsor: Janssen Research & Development, LLC
Sex: Female
Age: 18 - 45
Code: NCT06533098
Phase 3, Recruiting
Image Detection of Impaired Microcirculatory Reperfusion
for
Ischemic Stroke, Acute, Large Vessel Occlusion
Location: Cincinnati OH
Sponsor: University of Cincinnati
Sex: All
Age: 18+
Code: NCT07099599
Recruiting
Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
for
Renal Impairment After Cardiac Surgery, Renal Impairment,
Location: Cincinnati OH, Ann Arbor MI, Chapel Hill NC, Weston FL
Sponsor: 3ive Labs
Sex: All
Age: 22 - 70+
Code: NCT07017933
Recruiting
Telerehabilitation In The Home After Stroke
for
Stroke
Location: Cincinnati OH, Ann Arbor MI, Cleveland OH, Atlanta GA,
Sponsor: University of California, Los Angeles
Sex: All
Age: 18 - 70+
Code: NCT06682429
Recruiting
MAPT Protocol: Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP)
for
Femoral Neck Fractures
Location: Cincinnati OH, Bloomington IN, Nashville TN, London,
Sponsor: University of Southern California
Sex: All
Age: 60+
Code: NCT07244211
Recruiting
Use of Immunosuppressive Therapy for Sarcoidosis
for
Sarcoidosis
Location: Cincinnati OH
Sponsor: University of Cincinnati
Sex: All
Age: 15 - 70+
Code: NCT02356445
Recruiting
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
for
Primary Myelofibrosis
Location: Cincinnati OH, Columbus OH, Ann Arbor MI, St Louis MO,
Sponsor: Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company